This is Kedaara’s second investment in the single specialty healthcare area. Kedaara seeks to assist and fuel Oasis’ expansion towards realizing its ambition of becoming the most respected and leading fertility chain in India and adjacent markets with this $50 million deal and a commitment to deploy more funds for strategic acquisitions.
The investment seeks to strengthen Oasis’ organic expansion and accelerate inorganic partnerships across India and adjacent markets in order to further its vision of being a research-driven, clinical excellence-oriented fertility platform.
The transaction will also give an exit for InvAscent, which invested in the company in 2016. Oasis Fertility’s legal counsel was Samvad Partners, while Oasis Fertility’s exclusive finance advisor was O3 Capital. InvAscent’s legal counsel was Quillon Partners, and Kedaara Capital’s legal counsel was Veritas Legal.
